Acessibilidade / Reportar erro

Advances and trends in vision research

Avanços e tendências em pesquisa visual

Texto completo disponível apenas em PDF.

REFERENCES

  • 1
    GARLAND DL, RUSSELL P, ZIEGLER JS Jr. - Oxidative modification of lens proteins. In: SIMIC MG, TAYLOR KA, WARD JF, VON SONNTAG C, eds. Oxygen radicals in biology and medicine. New York: Plenum Press, Basic Life Sciences. 1988; 49; 347.
  • 2
    JOSÉ NK, CONTRERAS F, CAMPOS MA, DELGADO AM, MOWERY RL, ELLWEIN LB. - Screening and surgical intervention results from cataract-free-zone projects in Campinas, Brazil and Chimbote, Peru. Int Ophthalmol. 1990; 14: 155-164.
  • 3
    CONTRERAS F, CAMPOS M. - Peru Cataract-Free Zone Research Group. A population-based study to eliminate cataracts in Chimbote, Peru. Invest Ophthal Vis Sci. 1988; 29: 361.
  • 4
    JOSÉ NK. - Brazil Cataract-Free Zone Research Group. A population-based study to eliminate cataracts in a slum area in Campinas, Brazil. Invest Ophthal Vis Sci. 1988; 29: 361.
  • 5
    Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration: Results of a randomized clinical trial. Arch Ophthalmol. 1982; 100: 912-918.
  • 6
    SPERDUTO RD, FERRIS FL, KURINIJ N. - Do we have a nutritional treatment for age-related cataract and macular degeneration? Arch Ophthalmol. 1990; 108: 1403-1405.
  • 7
    The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976; 81: 383-396.
  • 8
    The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy; The second report of Diabetic Retinopathy Study findings. Am J Ophthalmol. 1978; 85: 82-106.
  • 9
    Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. ETDRS Report Number 1. Arch Ophthalmol. 1985; 103: 1796-1806.
  • 10
    Early Treatment Diabetic Retinopathy Study Research Group. Treatment techinques and clinical guidelines for photocoagulation of diabetic macular edema. ETDRS Report Number 2. Ophthalmology. 1987; 94: 761-74.
  • 11
    Early Treatment Diabetic Retinopathy Study Research Group. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy. ETDRS Report Number 3. Int Ophthalmol. 1987; 27: 254-64.
  • 12
    The EDTRS Research Group. Early Treatment Diabetic Retinopathy Study early photocoagulation for diabetic retinopathy. EDTRS Report Number 9. Ophthalmology. 1991; 98: 766-785.
  • 13
    Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe proliferarative diabetic retinopathy in eyes with useful vision. Ophthalmology. 1988; 95: 1307-1320.
  • 14
    KINOSHITA JR, KADOR P, DATILES M. - Aldose reductase in diabetic cataracts. JAMA. 1981; 246: 257-261.
  • 15
    KUWABARA T, COGAN DG. - Retinal vascular patterns, VI: mural cells of retinal capillaires. Arch Ophthalmol. 1963; 69: 492-502.
  • 16
    CHANDLER ML, SHANNON WA, DESANTIS L. - Prevention of retinal capillary basement membrane thickening in diabetic rats by aldose reductase inhibitors. Invest Ophthalmol Vis Sci. 1984; 25(suppl): 159.
  • 17
    ROBISON WG, NAGATA M, LAVER N, HOHMAN, KINOSHITA JH. - Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest Ophthalmol Vis Sci. 1989; 30: 2285-2292.
  • 18
    COGAN DG, KINOSHITA JH, KADOR PF, et al. - Aldose reductase and complications of diabetes. Ann Intern Med. 1984; 101: 82-91.
  • 19
    PAGE MG, HUTSON NJ, eds. - The effects of sorbinil on the pathophysiology of diabetic complications. Metabolism. 1986; 35: 1-121.
  • 20
    The Sorbinil Retionopathy Trial Research Group. A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Arch Ophthalmol. 1990; 108: 1234-1244.
  • 21
    Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT): 3. Designs and methods. Controlled Clin Trials. 1991; 12: 504-524.
  • 22
    Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT): 2. Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology. 1990; 97: 1403-1413.
  • 23
    The Fluorouracil Filtering Study Group. Fluorouracil Filtering Surgery Study one year follow-up. Am J Ophthalmol. 1989; 108: 625-635.
  • 24
    POLANSKY JR, WEINREB RN, BAXTER JD, ALVORADO J. - Human trabecular cells: 1. Establishment in tissue culture and growth characteristics. Invest Ophthalmol Vis Sci. 1979; 18: 1043-1049.
  • 25
    JOHNSON DH, TSCHUMPER RC. - Organ culture of human trabecular meshwork. A new model. Invest Ophthalmol Vis Sci. 1987; 28:945-953.
  • 26
    COURTRIGHT P, SHEPPARD J, SCHACHTER J, SAIO ME, DAWSON CR. Trachoma and blindness in the Nile Delta: current patterns and projections or the future in the rural Egyptian population. BJO. 1989; 73: 536-540.
  • 27
    SHEW J-Y, LIN BT-Y, CHEN P-L, FENGYANG TL, LEE W-H. - C-terminal truncation of the RB protein leads to functional inactivation. Proc Natl Acad Sci. 1990; 87: 6-10.

Datas de Publicação

  • Publicação nesta coleção
    Jul-Aug 1992
Conselho Brasileiro de Oftalmologia Rua Casa do Ator, 1117 - cj.21, 04546-004 São Paulo SP Brazil, Tel: 55 11 - 3266-4000, Fax: 55 11- 3171-0953 - São Paulo - SP - Brazil
E-mail: abo@cbo.com.br